Archive

Brics health cooperation expands across nine priority areas as member states strengthen efforts to achieve universal health coverage.

South Africa’s progress towards universal health coverage will depend on practical reforms that make quality healthcare more affordable and accessible. One of the biggest barriers is the outdated framework governing prescribed minimum benefits, or PMBs. PMBs are the conditions and services that every medical scheme must cover. They protect members from losing access to essential […]

Avoidable blindness in Africa remains one of the continent’s most serious eye health challenges. Millions of people continue to experience vision loss caused by cataracts, glaucoma, diabetic retinopathy and uncorrected refractive errors. Many of these conditions can be treated or managed when detected early. However, patients often reach specialists after significant vision loss has already […]

Lenacapavir production moves closer in SA as three local pharmaceutical manufacturers are shortlisted to produce the HIV-prevention injection.

South Africa’s population grew by an estimated 1.2% in the year to June 2026. This brought the total population to 63.52 million, according to the latest mid-year population estimates from Statistics South Africa. The rate was broadly unchanged from 2025. During that year, the population increased by 1.23% to 63.1 million. South Africa’s population has […]

Sixty60 pharmacy delivery could reset South Africa’s chemist market, letting Shoprite’s Medirite challenge Clicks and Dis-Chem.

Older adults with HIV will nearly double by 2040. South Africa faces one of the sharpest rises, straining health systems.

Rosebank Health Village, a R100 million Growthpoint and Epione development, brings specialists, diagnostics and day surgery together.

Global HIV funding cuts pushed financing to a 20-year low in 2025, threatening prevention, research and the goal of ending AIDS by 2030.

Aspen HIV prevention pill licensing deal positions the SA manufacturer to supply lower-cost monthly PrEP across key African markets.

The Dis-Chem leadership succession ends as co-founder Ivan Saltzman leaves the board after 48 years, ending the family’s representation.